Who Owns eXoZymes Stock?
NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 1.34%
- Held by insiders
- 65.35%
- Institutional holders
- 10
- Institutions 1.3%
- Insiders 65.4%
- Public and other 33.3%
Who owns eXoZymes stock?
Institutional investors own about 1.3% of eXoZymes's shares, spread across 10 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 65.35% of EXOZ.
The largest institutional holders are Vanguard Capital Management LLC (0.59%), Davidson Kahn Capital Management, LLC (0.27%) and Geode Capital Management, LLC (0.25%). Together, the top 9 institutions control 1.3% of shares outstanding. In their latest filings, 6 of the top 9 institutions increased their EXOZ positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EXOZ
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 54.98K | 0.59% | +147.8% |
| Davidson Kahn Capital Management, LLC | 25.00K | 0.27% | +100.0% |
| Geode Capital Management, LLC | 23.41K | 0.25% | +6.9% |
| Blackrock Inc. | 9.61K | 0.10% | +41.4% |
| Vanguard Fiduciary Trust Co | 9.43K | 0.10% | 0.0% |
| Morgan Stanley | 1.25K | 0.01% | 0.0% |
| Tower Research Capital LLC (TRC) | 349 | 0.00% | -73.5% |
| UBS Group AG | 203 | 0.00% | +745.8% |
| Barclays Plc | 75 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EXOZ
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 25.88K | 0.28% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 22.34K | 0.24% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 11.79K | 0.13% |
| iShares Trust-iShares Micro-Cap ETF | 9.11K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.94K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.02K | 0.02% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 2.00K | 0.02% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 443 | 0.00% |
Frequently asked questions
Who is the largest shareholder of eXoZymes?
Vanguard Capital Management LLC is the largest institutional shareholder of EXOZ, owning 0.59% of shares outstanding (54.98K shares) as of its latest 13F filing.
What percentage of eXoZymes is owned by institutions?
Institutions own about 1.3% of EXOZ shares and 3.9% of the public float.
How much of eXoZymes do insiders own?
Insiders, such as officers and directors, own about 65.35% of EXOZ shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.